Passionflower for Sleep Quality

Sleep Quality — scientific infographic poster

The Ngan and Conduit 2011 double-blind placebo-controlled crossover trial of passionflower tea, published in Phytotherapy Research, demonstrated a small but statistically significant improvement in subjective sleep quality on a six-point Likert scale in 41 healthy adults with mild sleep disturbance. The effect was modest but the methodology was rigorous: each participant served as their own control, drinking passionflower tea one week and matched placebo tea the next, with sleep diaries scored daily. Passionflower's contribution to sleep is best understood as gentle reduction of sleep latency and improvement of subjective sleep quality, particularly in patients whose insomnia is driven by an anxious, ruminating mind — rather than the powerful hypnotic effect of a Z-drug like zolpidem or the histamine-antagonism sedation of diphenhydramine. The European phytopharmaceutical tradition has paired passionflower with valerian and hops for over a century in standardized sleep formulations; a 2013 trial in India found a valerian-passionflower-hops tablet did as well as zolpidem over two weeks. This deep-dive walks through the trial evidence, the patient profile that benefits most, the dosing strategies that work, the combination products, and why passionflower produces gentle sedation without the next-day grogginess, rapid eye movement (REM) sleep disruption, and dependence liability of conventional sleep medications.


Table of Contents

  1. The Ngan & Conduit 2011 Sleep Tea Trial
  2. Effect on Sleep Architecture (Polysomnography Data)
  3. Passiflora-Valerian-Hops Combinations
  4. Sleep Latency vs Sleep Maintenance
  5. Which Patients Benefit Most
  6. Why No Next-Day Grogginess
  7. Comparison with Conventional Sleep Medications
  8. Practical Dosing for Sleep
  9. Passionflower in the Context of Sleep Hygiene
  10. Cautions
  11. Key Research Papers
  12. Connections
  13. Featured Videos

The Ngan & Conduit 2011 Sleep Tea Trial

The most directly relevant clinical evidence for passionflower as a sleep aid is the Ngan and Conduit 2011 trial published in Phytotherapy Research. The Swinburne University investigators designed a double-blind placebo-controlled crossover study specifically to test whether everyday passionflower herbal tea, brewed at home in a household-realistic dose, would produce measurable improvement in subjective sleep quality in adults with mild sleep disturbance.

Forty-one adults (18-35 years old) with self-reported mild sleep disturbance were enrolled. The crossover design assigned each participant to:

The placebo tea was designed to be sensorially indistinguishable: similar color, aroma, and taste, achieved by using a different botanical that did not contain passionflower's active flavonoids. Participants were blinded to treatment order. Sleep quality was assessed daily with a six-point sleep quality rating scale and weekly with the Spielberger State-Trait Anxiety Inventory.

Results:

The trial deserves attention for two reasons. First, it tested a household-realistic intervention — a cup of tea before bed — rather than a high-dose standardized extract that few real-world users would take. Second, the crossover design substantially increases statistical power by using each participant as their own control, controlling for individual differences in baseline sleep quality and tea-drinking expectations. The conclusion is reasonably robust: passionflower tea produces a small but real improvement in subjective sleep quality in healthy adults with mild sleep complaints.

Limitations: the trial population was healthy young adults with mild sleep complaints, not clinical insomnia. Effect on serious insomnia disorder requires different evidence. And although ten participants also had an overnight sleep-laboratory recording (polysomnography) on the last night of each treatment week, the abstract reports a difference only for self-rated sleep quality — one of six sleep-diary measures — and reports no objective sleep-architecture difference. The authors describe the tea as a low dose and the participants as healthy adults with mild fluctuations in sleep quality.

Back to Table of Contents

Effect on Sleep Architecture (Polysomnography Data)

No sleep-laboratory (polysomnography) study of passionflower alone, or of a passionflower combination product, was found. The sleep-architecture data usually quoted in this area come from valerian alone. In the Schulz 1994 pilot study, 14 older poor sleepers had overnight polysomnography; eight took a valerian extract (405 mg three times a day for seven days) and six took placebo:

A separate 1998 study by Schulz and colleagues was a single-dose brain-wave (quantitative EEG) screening study in two groups of 12 women. It tested eight plant extracts one at a time — including passionflower and valerian — against placebo and diazepam 10 mg, recording the EEG 2 and 3 hours after the dose. Some extracts increased theta-band power, unlike diazepam, and self-rated tiredness rose with diazepam and with some of the extracts. It was not a sleep study and did not test a combination product.

The preservation of slow-wave and REM sleep is mechanistically important. Slow-wave sleep is critical for physical restoration, glymphatic clearance of brain metabolites, and memory consolidation. REM sleep is critical for procedural memory consolidation and emotional processing. Sleep medications that suppress these sleep stages produce subjectively longer sleep that is qualitatively inferior — the well-known phenomenon of feeling unrefreshed after a long night on a high-dose Z-drug. Whether passionflower affects these sleep stages has not been measured in a sleep-laboratory study.

For animal and cell evidence, the Toda 2017 study looked at the body clock (circadian clock genes such as Per2, Cry1, Bmal1 and Clock) in cultured cells and in mice. In mice, passionflower extract at 100 mg/kg a day for 15 days improved sleep latency and sleeping time in a test where sleep is induced with the drug pentobarbital, similar to the gamma-aminobutyric acid (GABA) drug muscimol, and it raised brain dopamine levels at one point in the night cycle. The study did not measure non-REM or REM sleep stages or orexin, the brain's wake-promoting signal.

Back to Table of Contents

Passiflora-Valerian-Hops Combinations

The European phytopharmaceutical tradition has paired passionflower with valerian (Valeriana officinalis) and often hops (Humulus lupulus) in standardized sleep formulations for over a century. The combination is mechanistically rational because each herb works through complementary GABAergic mechanisms:

Three examples of the combination:

  1. German passionflower-valerian-hops tablets — standardized passionflower-valerian-hops dry extract, typically 200-400 mg per tablet, used as evening sleep aid
  2. Swiss passionflower-plus-valerian formulations — passionflower plus valerian without hops, marketed for sleep latency reduction
  3. NSF-3 (study formulation tested by Maroo 2013) — a tablet of standardized valerian, passionflower and hops extracts, tested for primary insomnia in India against the sleeping pill zolpidem

The Schulz sleep studies did not test a passionflower combination (see the section above). In the Maroo 2013 double-blind trial in India, 91 adults with primary insomnia (sleeping under 6 hours a night) took either one NSF-3 tablet or zolpidem 10 mg at bedtime for two weeks; 39 in each group finished. Both groups improved in total sleep time, time to fall asleep, night wakings and insomnia severity scores, with no statistically significant difference between them. Daytime sleepiness scores did not change significantly. There were 12 side-effect reports with NSF-3 and 16 with zolpidem, most often drowsiness, mostly mild and none serious. Whether the benefit lasts, and whether the tablet causes dependence with long-term use, was not studied. The combination approach trades the simplicity of a single-herb intervention for complementary mechanisms.

Back to Table of Contents

Sleep Latency vs Sleep Maintenance

The published evidence supports passionflower's effect predominantly on sleep latency (the time it takes to fall asleep) and subjective sleep quality, rather than on sleep maintenance (the ability to stay asleep through the night) or early-morning awakening. This is consistent with passionflower's short pharmacokinetic profile — the active flavonoids are rapidly absorbed and produce a 4-6 hour window of effect, sufficient to ease sleep onset but not necessarily to maintain pharmacologic effect through an 8-hour sleep period.

Clinical implication: passionflower is best matched to insomnia phenotypes characterized by:

Passionflower is a poor match for insomnia phenotypes characterized by:

For other natural sleep approaches, see our Sleep Hygiene page and the Insomnia page.

Back to Table of Contents

Which Patients Benefit Most

The patient profile that has consistently responded best to passionflower in the published trials is reasonably well-characterized:

Patients with severe primary insomnia, obstructive sleep apnea, restless leg syndrome, or insomnia secondary to active major depressive disorder require different evaluation and treatment; passionflower is not the right primary intervention.

Back to Table of Contents

Why No Next-Day Grogginess

One of passionflower's most clinically valued attributes is the absence of next-day grogginess, cognitive slowing, or motor impairment — the "hangover" effect that limits many sleep medications. The mechanism for this clean morning profile is twofold:

  1. Short pharmacokinetic profile — the active flavonoids in passionflower have plasma half-lives in the 4-6 hour range, meaning they are substantially eliminated by morning even when taken at bedtime. Contrast with long-acting benzodiazepines (diazepam, flurazepam) that have active metabolites with half-lives of 40-100+ hours, accumulating with daily use and producing significant morning impairment
  2. Partial-agonist, low-affinity binding — even at peak plasma concentration, passionflower produces only modest gamma-aminobutyric acid-A potentiation. The arousal systems are dampened enough to permit sleep onset but not clamped to the degree that cortical recovery in the morning is delayed

No study found has measured next-morning thinking and coordination tests after passionflower or a passionflower combination. In the Maroo 2013 trial of a valerian-passionflower-hops tablet, daytime sleepiness scores (Epworth scale) did not change significantly over two weeks. Morning alertness matters most for people who need to drive, operate machinery, perform demanding cognitive work, or care for young children early the next morning.

The clinical translation: these points matter most to people who experience morning fog with zolpidem or diphenhydramine and who look at passionflower or a passionflower combination as a substitute or supplement.

Back to Table of Contents

Comparison with Conventional Sleep Medications

A practical comparison framework for thinking about where passionflower fits in the sleep-aid landscape:

For severe primary insomnia, the gold-standard intervention is cognitive behavioral therapy for insomnia (CBT-I), which produces durable improvement that medication cannot match. Passionflower is best used as part of an overall sleep approach that includes good sleep hygiene, environmental optimization, and where appropriate, cognitive behavioral therapy for insomnia.

Back to Table of Contents

Practical Dosing for Sleep

For sleep-specific use, the dosing skews higher than for daytime anxiolysis and is concentrated in a single evening dose 30-60 minutes before bedtime:

Onset of effect for sleep is 30-60 minutes after the oral dose, peak at 60-90 minutes, with the effect window covering the first 4-6 hours of sleep — precisely the period during which sleep-onset insomnia and early-night awakening occur.

The dosing strategy that works best is consistency: nightly use for 1-2 weeks to allow the gentle effect to accumulate, rather than as-needed use only on bad nights. No tolerance to passionflower with chronic use has been documented (unlike benzodiazepines and Z-drugs).

Back to Table of Contents

Passionflower in the Context of Sleep Hygiene

Passionflower works best when layered onto a foundation of good sleep hygiene rather than substituted for it. The principles that any sleep intervention — pharmacologic or botanical — cannot overcome:

The combination of solid sleep hygiene plus passionflower tea before bed plus targeted stress management is far more effective than any single intervention alone. Detail on the comprehensive approach is on the Sleep Hygiene page.

Back to Table of Contents

Cautions

Back to Table of Contents

Key Research Papers

  1. Ngan A, Conduit R (2011). A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata (passionflower) herbal tea on subjective sleep quality. Phytotherapy Research, 25(8), 1153-1159. — PubMed PMID: 21294203
  2. Maroo N, Hazra A, Das T (2013). Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. Indian Journal of Pharmacology, 45(1), 34-39. — PubMed PMID: 23543804
  3. Schulz H, Stolz C, Muller J (1994). The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study. Pharmacopsychiatry, 27(4), 147-151. — PubMed PMID: 7972346
  4. Schulz H, Jobert M, Hübner WD (1998). The quantitative EEG as a screening instrument to identify sedative effects of single doses of plant extracts in comparison with diazepam. Phytomedicine, 5(6), 449-458. — PubMed PMID: 23196028
  5. Soulimani R, Younos C, Jarmouni S, Bousta D, Misslin R, Mortier F (1997). Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. Journal of Ethnopharmacology, 57(1), 11-20. — PubMed PMID: 9234160
  6. Spinella M (2001). The psychopharmacology of herbal medicine: plant drugs that alter mind, brain, and behavior. MIT Press. (Book; not indexed in PubMed.)
  7. Wheatley D (2005). Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. Journal of Psychopharmacology, 19(4), 414-421. — PubMed PMID: 15982998
  8. Toda K, Hitoe S, Takeda S, Shimizu N, Shimoda H (2017). Passionflower extract induces high-amplitude rhythms without phase shifts in the expression of several circadian clock genes in vitro and in vivo. International Journal of Biomedical Science, 13(2), 84-92. — PubMed PMID: 28824345
  9. Krenn L (2002). Passion flower (Passiflora incarnata L.) — a reliable herbal sedative. Wiener Medizinische Wochenschrift, 152(15-16), 404-406. — PubMed PMID: 12244887
  10. Miroddi M, Calapai G, Navarra M, Minciullo PL, Gangemi S (2013). Passiflora incarnata L.: ethnopharmacology, clinical application, safety and evaluation of clinical trials. Journal of Ethnopharmacology, 150(3), 791-804. — PubMed PMID: 24140586
  11. Patel SS, Soni H, Mishra K, Singhai AK (2009). Recent updates on the genus Passiflora: a review. International Journal of Research in Phytochemistry & Pharmacology, 1(1), 1-16. (Not indexed in PubMed.)
  12. Brown E, Hurd NS, McCall S, Ceremuga TE (2007). Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. AANA Journal, 75(5), 333-337. — PubMed PMID: 17966676
  13. Janda K, Wojtkowska K, Jakubczyk K, Antoniewicz J, Skonieczna-Żydecka K (2020). Passiflora incarnata in neuropsychiatric disorders — a systematic review. Nutrients, 12(12), 3894. — PubMed PMID: 33352740

PubMed Topic Searches

  1. PubMed: Passiflora sleep trials
  2. PubMed: Passiflora-Valerian-Hops
  3. PubMed: Herbal sleep polysomnography
  4. PubMed: Sleep latency herbal RCT
  5. PubMed: Natural sleep aids vs benzo

Back to Table of Contents

Connections

Back to Table of Contents